Furthermore, high expression of IL-6 in serum and tumor tissue, as well as marked expression of interleukin-17 (IL-17) in peritumoral cells negatively correlated with overall survival (OS) and disease-free survival (DFS) in patients who underwent surgical resection of iCCA [47]. This evidence concerns the gene IL17A and neoplasm.